A successful regulatory turnaround for a UK EMI and crypto firm, restoring FCA permissions and avoiding administration under new leadership.
Payment Services & Card/ Merchant Acquirers
A UK-based financial services firm authorised by the Financial Conduct Authority (FCA) as an Electronic Money Institution (EMI) and registered as a cryptoasset firm. The client operates in both traditional and digital finance sectors.
Under previous management, the client lost its FCA permissions and faced significant operational and reputational risks. With the business nearing administration, core investors required urgent intervention to stabilise the company, protect its regulatory standing, and restore its ability to operate lawfully in the UK market.
Our specialist consultant was appointed by the client’s core investors to lead a regulatory turnaround. This involved immediate stakeholder engagement, regulatory remediation, and the preparation and submission of detailed documentation to the FCA. We managed the full reinstatement process, liaising directly with the regulator, and ensuring the firm addressed all compliance shortcomings.
• FCA permissions successfully reinstated for both EMI and cryptoasset activities
• Regulatory confidence restored, enabling the client to continue operations
• Avoided administration and positioned the firm for renewed growth under strengthened governance and investor oversight
A U.K. Branch of a major Asian bank needed an in-depth review and enhancement of their AML governance framework. Lysis conducted a success review and drafted all required policies & procedures, and established a KYC Target Operating model.
The client is incorporated in Ireland as an Irish Collective Asset-management Vehicle (ICAV). The client is an American investment fund which specialises in lending large amounts of money to various entities ranging from listed entities to unregulated entities based in the USA.
A European investment bank had a surge in hits from screening and on-going monitoring in relation to PEPs, sanctions and adverse media monitoring.
